From: Hospital costs of nosocomial multi-drug resistant Pseudomonas aeruginosa acquisition
Independent variable | Coefficient | (95% CI) | P |
---|---|---|---|
Antibiotic susceptibility pattern | |||
Non-resistant | 1.00 | ||
Resistant | 1.37 | (1.08-1.72) | 0.009 |
Multi-drug resistant | 1.77 | (1.41-2.22) | <0.001 |
Sex, male | 1.12 | (0.91-1.37) | 0.277 |
Age | 1.00 | (0.98-1.00) | 0.161 |
Source of infection | |||
Respiratory | 0.91 | (0.67-1.22) | 0.538 |
Skin & soft tissue | 0.85 | (0.61-1.16) | 0.311 |
Genitourinary | 0.96 | (0.67-1.36) | 0.827 |
Clinical conditions | |||
Chronic obstructive pulmonary disease | 0.79 | (0.62-1.00) | 0.045 |
Solid neoplasm | 1.00 | (0.79-1.24) | 0.979 |
Diabetes mellitus | 1.22 | (0.96-1.55) | 0.102 |
Renal disease | 0.85 | (0.61-1.16) | 0.313 |
Liver disease | 1.20 | (0.87-1.65) | 0.261 |
UCI stay post infection | 3.46 | (2.70-4.41) | <0.001 |
Average total cost per DRG | 1.43 | (1.28-1.60) | <0.001 |
In-hospital mortality | 0.96 | (0.75-1.21) | 0.720 |